This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Brainsway is proud to announce that we have sold our first Deep TMS system within Switzerland. The system was purchased by a clinic focusing on depression and chronic pain management. The CE has certified Deep TMS as a treatment for these indications. The sale of this system is another milestone for the comapny, and a positive indication for their penetration of the European market.
Read more here.